المؤلفون: Nobre DAB; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Moura MDG; Department of Dentistry, Centro Universitário Vale do Rio Verde - UNINCOR, Belo Horizonte, Brazil., de Arruda JAA; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Felix FA; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Diniz PB; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Duarte ECB; Department of Pathology, School of Medicine, Universidade de Brasília, Brasília, Brazil., Abreu LG; Department of Child and Adolescent Oral Health, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Gomez RS; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Mesquita RA; Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

المصدر: International journal of STD & AIDS [Int J STD AIDS] 2024 Jul; Vol. 35 (8), pp. 627-634. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Leukoplakia, Hairy*/drug therapy , Leukoplakia, Hairy*/virology , Herpesvirus 4, Human*/genetics , Herpesvirus 4, Human*/isolation & purification , Acyclovir*/therapeutic use , Acyclovir*/administration & dosage , Administration, Topical* , DNA, Viral*/analysis , Epstein-Barr Virus Infections*/drug therapy , Epstein-Barr Virus Infections*/virology, Humans ; Female ; Male ; Middle Aged ; Adult ; Podophyllin/therapeutic use ; Podophyllin/administration & dosage ; Treatment Outcome ; HIV Infections/drug therapy ; HIV Infections/virology ; Polymerase Chain Reaction ; Guanine/analogs & derivatives ; Guanine/therapeutic use ; Guanine/administration & dosage

المؤلفون: Maćkowiak K; Department of Laboratory Diagnostic, Dr Jan Biziel University Hospital No. 2, Bydgoszcz, Poland., Jankowiak M; Department of Laboratory Diagnostic, Dr Jan Biziel University Hospital No. 2, Bydgoszcz, Poland., Szewczyk-Golec K; Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland., Hołyńska-Iwan I; Department of Pathobiochemistry and Clinical Chemistry, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.

المصدر: Biochemia medica [Biochem Med (Zagreb)] 2024 Jun 15; Vol. 34 (2), pp. 020502.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Croatian Society for Medical Biochemistry and Laboratory Medicine Country of Publication: Croatia NLM ID: 9610305 Publication Model: Print Cited Medium: Internet ISSN: 1846-7482 (Electronic) Linking ISSN: 13300962 NLM ISO Abbreviation: Biochem Med (Zagreb) Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/diagnosis , Leukemia, Hairy Cell*/therapy, Humans ; Male ; Diagnosis, Differential ; Mutation ; Proto-Oncogene Mas ; Proto-Oncogene Proteins B-raf/genetics ; Sex Factors

المؤلفون: Grever M; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA. michael.grever@osumc.edu., Andritsos L; Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA., Anghelina M; Center for Biostatistics, The Ohio State University, Columbus, OH, USA., Arons E; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Banerji V; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, and Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada., Barrientos J; Mount Sinai Medical Center Miami, Miami, FL, USA., Bhat SA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Blachly J; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Broccoli A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy., Call T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dearden C; The Royal Marsden NHS Foundation Trust, London, UK., Dietrich S; University Hospital of Düsseldorf, Düsseldorf, Germany., Else M; The Institute of Cancer Research, London, UK., Epperla N; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Fagarasanu A; University of Alberta, Edmonton, AB, Canada., Falini B; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Forconi F; Cancer Sciences and Haematology Department, University of Southampton and Cancer Care, Haematology Department, Southampton NHS University Hospital Trust, Southampton, UK., Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena Policlinico S Maria alle Scotte, Siena, Italy., Hampel P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hermel DJ; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Iyengar S; The Royal Marsden NHS Foundation Trust, London, UK., Johnston JB; Department of Medicine, University of Manitoba, Winnipeg, MB, Canada., Juliusson G; Lund University/Dept of Hematology, Skåne University Hospital, Lund, Sweden., Kreitman RJ; Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA., Lauria F; University of Siena, Siena, Italy., Lozanski G; Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA., Oakes CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Park J; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Quest G; Pathology and Molecular Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada., Rai K; Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robak T; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Rogers KA; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA., Saven A; Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital & University of Melbourne, Melbourne, VIC, Australia., Tadmor T; Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Tallman MS; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia., Tiacci E; Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy., Troussard X; Department of Hematology, Centre Hospitalier Universitaire Cote de Nacre, Caen, France., Wörmann B; The Charité - Universitätsmedizin, Berlin, Germany., Zent CS; James P. Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Zenz T; Dept. of Medical Oncology & Haematology, Univerity Hospital and University of Zurich; The LOOP Zurich - Medical Research Center, Zurich, Switzerland., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico 'Sant'Orsola-Malpighi', and Department of Medical and Surgical Sciences - University of Bologna, Bologna, Italy.

المصدر: Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1642-1644. Date of Electronic Publication: 2024 Jun 08.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/pathology , Leukemia, Hairy Cell*/classification , Leukemia, Hairy Cell*/diagnosis , World Health Organization*, Humans

المؤلفون: Jiang K; University British Columbia, Vancouver, B.C.. Electronic address: kailunjiang@gmail.com., Punja KG; University of Calgary, Calgary, Alta., Hyrcza MD; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alta., Simpson SM; Queen's University, Kingston, Ont.

المصدر: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Jun; Vol. 59 (3), pp. e285-e287. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1715-3360 (Electronic) Linking ISSN: 00084182 NLM ISO Abbreviation: Can J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/diagnosis , Orbital Neoplasms*/diagnosis , Orbital Neoplasms*/diagnostic imaging, Humans ; Male ; Magnetic Resonance Imaging ; Tomography, X-Ray Computed ; Middle Aged ; Orbit/diagnostic imaging ; Biopsy

المؤلفون: Panovská A; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Žák P; 4th Department of Internal Medicine-Hematology, University Hospital and Charles University Faculty of Medicine, Hradec Králové, Czech Republic., Jurková T; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic., Arpáš T; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Brychtová Y; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Vašíková A; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Hrabčáková V; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Prchlíková A; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Filipová M; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic., Doubek M; Department of Internal Medicine-Hematology and Oncology, University Hospital and Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

المصدر: Hematological oncology [Hematol Oncol] 2024 May; Vol. 42 (3), pp. e3280.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/diagnosis , Leukemia, Hairy Cell*/drug therapy , Leukemia, Hairy Cell*/pathology , Leukemia, Hairy Cell*/mortality , Leukemia, Hairy Cell*/therapy, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Adult ; Aged, 80 and over ; Treatment Outcome ; Cladribine/therapeutic use ; Cladribine/administration & dosage ; Follow-Up Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics

المؤلفون: Yiğit Kaya S; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Turkey. Electronic address: sureyya.yigitkaya@medipol.com.tr., Mutlu YG; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Malkan ÜY; Department of Hematology, Faculty of Medicine, Hacettepe University, Turkey., Mehtap Ö; Department of Hematology, Faculty of Medicine, Kocaeli University, Turkey., Keklik Karadağ F; Department of Hematology, Faculty of Medicine, Ege University, Turkey., Korkmaz G; Department of Hematology, Ankara Bilkent City Hospital, Turkey., Elverdi T; Department of Hematology, Cerrahpaşa Faculty of Medicine, Istanbul University, Turkey., Saydam G; Department of Hematology, Faculty of Medicine, Ege University, Turkey., Özet G; Department of Hematology, Ankara Bilkent City Hospital, Turkey., Ar MC; Department of Hematology, Cerrahpaşa Faculty of Medicine, Istanbul University, Turkey., Melek E; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Maral S; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Kaynar L; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Sevindik ÖG; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.

المصدر: Leukemia research [Leuk Res] 2024 May; Vol. 140, pp. 107495. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/drug therapy , Leukemia, Hairy Cell*/pathology , Vemurafenib*/administration & dosage , Vemurafenib*/therapeutic use , Vemurafenib*/adverse effects , Rituximab*/administration & dosage , Rituximab*/therapeutic use , Rituximab*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Aged ; Adult ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Treatment Outcome ; Aged, 80 and over ; Drug Resistance, Neoplasm

المؤلفون: Stark K; Department of Haematology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Rowe C; Department of Haematology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Mathur A; Department of Haematology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Matossian J; Department of Pathology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Lawrie A; Department of Haematology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.

المصدر: The journal of the Royal College of Physicians of Edinburgh [J R Coll Physicians Edinb] 2024 Mar; Vol. 54 (1), pp. 29-33. Date of Electronic Publication: 2023 Dec 30.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101144324 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-8189 (Electronic) Linking ISSN: 14782715 NLM ISO Abbreviation: J R Coll Physicians Edinb Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/complications , Leukemia, Hairy Cell*/drug therapy , Lymphohistiocytosis, Hemophagocytic*/chemically induced , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/drug therapy , Neoplasms*/complications , Sepsis*, Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects ; Male ; Middle Aged

المؤلفون: Gray AN; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus., Flood D; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus., Korman AM; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus.

المصدر: Cutis [Cutis] 2024 May; Vol. 113 (5), pp. E22-E24.

نوع المنشور: Case Reports; Journal Article; Letter

بيانات الدورية: Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Internet ISSN: 2326-6929 (Electronic) Linking ISSN: 00114162 NLM ISO Abbreviation: Cutis Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/complications , Leukemia, Hairy Cell*/diagnosis , Purpura*/diagnosis , Purpura*/etiology, Humans ; Male ; Middle Aged

المؤلفون: Troussard X; Laboratoire Hématologie, CHU Côte de Nacre, Caen Cedex, France., Maître E; Laboratoire Hématologie, CHU Côte de Nacre, Caen Cedex, France., Paillassa J; Service des Maladies du Sang, CHU Angers, Angers Cedex, France.

المصدر: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 679-696. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/diagnosis , Leukemia, Hairy Cell*/genetics , Leukemia, Hairy Cell*/therapy , Hematologic Neoplasms*/diagnosis , Hematologic Neoplasms*/genetics , Hematologic Neoplasms*/therapy, Humans ; Proto-Oncogene Proteins B-raf ; Immunotherapy ; B-Lymphocytes

المؤلفون: Ligia S; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Passucci M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Assanto GM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., D'Elia GM; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Annechini G; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., De Propris MS; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Tiacci E; Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy., Pulsoni A; Hematology, Department of Translational and Precision Medicine, Sapienza University, S.M. Goretti Hospital, Latina, Italy.

المصدر: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1288-1292. Date of Electronic Publication: 2023 Dec 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Hairy Cell*/pathology , Antineoplastic Agents*/therapeutic use, Humans ; Cladribine/therapeutic use ; Bone Marrow/pathology ; Retrospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local ; Immunologic Factors/therapeutic use ; Antimetabolites/therapeutic use